Mabel Mardones, M.D.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    Breast Cancer
    Date added:
    07/16/2025
    Date updated:
    07/16/2025
    Relationship end date:
    01/09/2026
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Advisor
    Date added:
    07/16/2025
    Date updated:
    07/16/2025
    Relationship end date:
    08/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Stemline
    Topic:
    Advisor
    Date added:
    07/16/2025
    Date updated:
    07/16/2025
    Relationship end date:
    08/21/2026
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    illy Lilly
    Topic:
    advisor
    Date added:
    07/16/2025
    Date updated:
    07/16/2025
    Relationship end date:
    01/07/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Astrazeneca
    Topic:
    advisor
    Date added:
    07/16/2025
    Date updated:
    07/16/2025
    Relationship end date:
    12/25/2026
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Agendia
    Topic:
    advisor
    Date added:
    07/16/2025
    Date updated:
    07/16/2025
    Relationship end date:
    02/10/2026
Return to Best of ASCO 2025, El Paso